Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1022820170080020019
Journal of Multiple Sclerosis and Neuroimmunology
2017 Volume.8 No. 2 p.19 ~ p.23
Multiple Sclerosis Market Understanding Study
Min Ju-Hong

Kim Byoung-Joon
Kim Kwang-Kuk
Abstract
Multiple sclerosis (MS) is a CNS demyelinating disorder, which affects young aged people. In Korea, the prevalence of MS is very lower than that of western countries. Now, more than 10 disease modifying therapeutics (DMTs) were discovered; therefore the early diagnosis and treatment optimization is very important in MS patients. Herein, to understand MS market in Korea, we investigated the current diagnostic strategy and therapeutic choice of DMTs by Korean MS specialists in real world practice
KEYWORD
Multiple sclerosis, Disease modifying therapeutic, Korea
FullTexts / Linksout information
Listed journal information